phar­mafakt has been sup­port­ing doc­tors’ and phar­macists’ pro­fes­sio­nal asso­cia­ti­ons, uni­ver­si­ty rese­arch and the phar­maceu­ti­cal indus­try sin­ce 1998 with com­pre­hen­si­ve, dif­fe­ren­tia­ted and fun­da­men­tal­ly data-based stu­dies and ana­ly­ses as well as pro­ven con­sul­ting exper­ti­se on all issues in the phar­maceu­ti­cal market.

phar­mafakt’s share­hol­ders include the phar­macists’ asso­cia­ti­ons of the fede­ral sta­tes of Bava­ria, Baden-Württemberg and Sax­o­ny and two lea­ding data-processing-centres.

The phar­mafakt con­sul­ting con­cept is based on data obtai­ned in data pro­ces­sing cen­tres for phar­maci­es during pre­scrip­ti­on sett­le­ment. This data is anony­mi­sed and made available to phar­mafakt.

The data is pro­ces­sed on a project-specific basis and in a cus­to­mi­sed way to crea­te sta­tis­tics and ana­ly­ses which are then available for phar­mafakt’s uni­que, indi­vi­du­al and data-based con­sul­ting expertise.

We call this data-backed phar­ma consulting.
The inno­va­ti­ve phar­mafakt con­cept - a tail­o­red business-to-business partnership